NUCLEOLIN and tuberous sclerosis: Intriguingly, hyperactivation of the mTORC1 pathway, is a hallmark of Tuberous Sclerosis (TSC) in patients as well Tsc1 or Tsc2 knockout mouse models, that present with a range of neurological disorders including epilepsy, relevant to NCL pathology [47,48].